Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer
Abstract Alterations in the epigenetic machinery in both tumor and immune cells contribute to bladder cancer (BC) development, constituting a promising target as an alternative therapeutic option. Here, we have explored the effects of a novel histone deacetylase (HDAC) inhibitor CM-1758, alone or in...
Main Authors: | Sandra P. Nunes, Lucia Morales, Carolina Rubio, Ester Munera-Maravilla, Iris Lodewijk, Cristian Suárez-Cabrera, Victor G. Martínez, Mercedes Pérez-Escavy, Miriam Pérez-Crespo, Miguel Alonso Sánchez, Esther Montesinos, Edurne San José-Enériz, Xabier Agirre, Felipe Prósper, Antonio Pineda-Lucena, Rui Henrique, Marta Dueñas, Margareta P. Correia, Carmen Jerónimo, Jesús M. Paramio |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-01-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-023-01786-3 |
Similar Items
-
Dual epigenetic modifiers for cancer therapy
by: Edurne San José-Enériz, et al.
Published: (2017-07-01) -
Explainable artificial intelligence for precision medicine in acute myeloid leukemia
by: Marian Gimeno, et al.
Published: (2022-09-01) -
COBRA methods and metabolic drug targets in cancer
by: Iñigo Apaolaza, et al.
Published: (2018-01-01) -
BOSO: A novel feature selection algorithm for linear regression with high-dimensional data.
by: Luis V Valcárcel, et al.
Published: (2022-05-01) -
A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism.
by: Iñigo Apaolaza, et al.
Published: (2022-03-01)